Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.8
Price to sales ratio
1.95

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1450
NVST
Envista Holdings Corporation Common Stock
26.21 USD+1.16%-5.52%+3.31%+27.11%4.27 B USD
1512
ICUI
ICU Medical, Inc. - Common Stock
157.60 USD+2.06%-1.64%+9.21%+27.42%3.94 B USD
1620
WRBY
Warby Parker Inc. Class A Common Stock
27.42 USD-5.61%-7.05%+0.51%+18.44%3.36 B USD
1835
XRAY
DENTSPLY SIRONA Inc. - Common Stock
12.78 USD+4.24%+2.73%+24.44%-3.03%2.56 B USD

Frequently asked questions about Haemonetics Corporation Common Stock

What is the Haemonetics Corporation Common Stock stock price today?

The current price of Haemonetics Corporation Common Stock (HAE) is 76.86. Over the past 24 hours, the stock has changed by +0.85%. Follow the HAE chart for real-time price dynamics.

What is the stock ticker of Haemonetics Corporation Common Stock?

Haemonetics Corporation Common Stock trades under the ticker HAE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Haemonetics Corporation Common Stock stock going up?

HAE has changed by +0.47% over the last week, -1.89% over the last month, and +50.35% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Haemonetics Corporation Common Stock net income for the last quarter?

Haemonetics Corporation Common Stock reported net income of -20.15 M for the last quarter. The previous quarter showed 44.74 M, which means net income changed by -145.03%.

How many employees does Haemonetics Corporation Common Stock have?

As of the latest available data, Haemonetics Corporation Common Stock has 3 009 employees. Workforce size can provide additional context about the company's scale and operations.

What is Haemonetics Corporation Common Stock EBITDA?

Haemonetics Corporation Common Stock EBITDA is 42.88 M, and its EBITDA margin is 12.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Haemonetics Corporation Common Stock stock?

You can buy Haemonetics Corporation Common Stock (HAE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Haemonetics Corporation Common Stock stock?

Investing in Haemonetics Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HAE chart and related analysis on metatrader.com as part of your research.

Haemonetics Corporation Common Stock

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.

News